NEW YORK (GenomeWeb) – Kailos Genetics has signed an agreement to allow Illumina to market its TargetRich research solutions for pharmacogenetic target enrichment.

The products included in the marketing and promotions arrangement are TargetRich PGxComplete and Kailos Blue. According to Kailos, PGxComplete is a research use only reagent for targeting genes that are associated with response to more than 100 medications. Kailos Blue is the company's automated data analysis solution and reporting software used with TargetRich reagents.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.